Chris Halyk
Direttore/Membro del Consiglio presso MEDIPHARM LABS CORP.
Patrimonio netto: 4 988 $ in data 31/05/2024
Posizioni attive di Chris Halyk
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MEDIPHARM LABS CORP. | Direttore/Membro del Consiglio | 04/08/2020 | - |
| Independent Dir/Board Member | 04/08/2020 | - |
Storia della carriera di Chris Halyk
Precedenti posizioni note di Chris Halyk
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Presidente | 01/01/2006 | 01/01/2019 |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Direttore/Membro del Consiglio | 01/01/2012 | 01/01/2013 |
| Ortho Biotech, Inc. | Corporate Officer/Principal | - | - |
Formazione di Chris Halyk
| Richard Ivey School of Business | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Canada | 4 |
| Hong Kong | 2 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 2 |
| President | 1 |
| Independent Dir/Board Member | 1 |
Settori
| Commercial Services | 2 |
| Health Technology | 2 |
| Process Industries | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MEDIPHARM LABS CORP. | Process Industries |
| Aziende private | 3 |
|---|---|
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Commercial Services |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
| Ortho Biotech, Inc. |
- Borsa valori
- Insiders
- Chris Halyk
- Esperienza
